Apotex Extends Formosa Ophthalmic Alliance Into Mexico
Already Held Canadian Rights To Novel Clobetasol Propionate Treatment
Apotex has expanded an alliance formed with Formosa in August for its novel clobetasol propionate ophthalmic treatment, adding Mexican rights to its existing deal for the Canadian market.
